← Eichor
Condition: Hyperlipoproteinemia A Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Hyperlipoproteinemia A

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

WeArable teChnology daTa driVen digitAl healTh cOachINg (ACTIVATION)- A Mixed-methods Study
NA · 1 location(s) · Alexandra Hospital · NCT06752772IBI306 Monotherapy in Non-Familial Hypercholesterolemia and Mixed Hyperlipidemia
Phase 3 · 1 location(s) · Innovent Biologics (Suzhou) Co. Ltd. · NCT07473960Bacillus Subtilis and Enterococcus Faecium Probiotic Plus Lipid-Lowering Therapy for Hypertriglyceridemic Acute Pancreat
Phase 4 · 1 location(s) · Jianyin Zhou · NCT07720232Pilot Study of "Bottarga" Supplementation: A Little-known, Sustainable "Blue" Food
NA · 1 location(s) · Cambridge Health Alliance · NCT06988462Whole Grain Job's Tear, Muscle Health, Blood Glucose and Lipid Level
Phase 2 · 1 location(s) · Taipei Veterans General Hospital, Taiwan · NCT06503172A Dose-exploration Study of EDP167 in HoFH
Phase 2 · 1 location(s) · Eddingpharm (Zhuhai) Co., Ltd. · NCT07489209A Study of SYH2070 Injection in Participants With Mixed Hyperlipidemia
Phase 2 · 1 location(s) · CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd. · NCT07695597AdLip: Human Coach-supported Digital/AI Personal Health Assistant to Improve Adherence to Lipid-Lowering Medication
NA · 2 location(s) · National University of Singapore · NCT06614049Atlantic Lipid Lowering Treatment Optimization Program
NA · 2 location(s) · Atlantic Health System · NCT06439654Ursodeoxycholic Acid Attenuates Statin-Induced Impaired Glucose Tolerance
NA · 2 location(s) · First Affiliated Hospital Xi'an Jiaotong University · NCT06684106To Compare the Effects of Herbal Medicines With Traditional Allopathic Medicines in Cases of Patients With Metabolic Syn
NA · 1 location(s) · Hamdard University · NCT06515652Effect of Fish Oil on Hyperlipidemia and Toxicities in Children and Young Adults With Acute Lymphoblastic Leukemia
NA · 4 location(s) · Rigshospitalet, Denmark · NCT04209244HoFH, the International Clinical Collaborators Registry
Phase N/A · 4 location(s) · University of Pennsylvania · NCT04815005A Real-World Study of Long-Term Adherence and Persistence to Inclisiran, Evolocumab, and Alirocumab
Phase N/A · 1 location(s) · Novartis Pharmaceuticals · NCT07543731Zhibitai Capsules for the Treatment of Primary Hyperlipidemia
Phase 2 · 1 location(s) · Chengdu Diao Jiuhong Pharmaceutical Factory · NCT06822946A Study to Evaluate the Safety, Efficacy of SYH2053 as Monotherapy in Chinese Participants With Non-familial Hypercholes
Phase 3 · 2 location(s) · CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd. · NCT07421297Integrating Whole Genome Sequencing and Digital Twins Into the Management of Hypercholesterolemia in Emiratis
NA · 1 location(s) · Abu Dhabi Health Services Company · NCT06535542Safety Evaluation of Gene Therapy Drug in the Treatment of Primary Hypertriglyceridemic Patients With Recurrent Pancreat
Phase 1 · 1 location(s) · GeneCradle Inc · NCT05860569A Study of VERVE-102 in Patients With Familial Hypercholesterolemia or Premature Coronary Artery Disease
Phase 1 · 24 location(s) · Verve Therapeutics, Inc. · NCT06164730Assessing the Impact of Intensification of Lipid Lowering Therapy With Guidelines-based Evinacumab Administration on Cor
Phase N/A · 13 location(s) · Fondazione SISA (Societa Italiana per lo Studio della Arteri · NCT07447648A Study to Evaluate COR-1004 in Adult Volunteers.
Phase 1 · 1 location(s) · Corsera Health · NCT07229118Using a Telehealth and Shared Decision-Making Model to Address Preventative Medicine Strategies Among Communities in Lou
NA · 1 location(s) · Xavier University of Louisiana. · NCT05676970A Clinical Study to Evaluate the Efficacy, Tolerability, and Safety of Bempedoic Acid
Phase 3 · 1 location(s) · Gan & Lee Pharmaceuticals. · NCT06780410NGGT006 Gene Therapy for Homozygous Familial Hypercholesterolemia
EARLY_Phase 1 · 1 location(s) · First Affiliated Hospital Xi'an Jiaotong University · NCT06125847A Study of SRSD216 in Patients With Elevated Lipoprotein (a)
Phase 1/Phase 2 · 1 location(s) · Sirius Therapeutics Co., Ltd. · NCT07172646National Network for Cardiovascular Genomics: Advancing Cardiovascular Healthcare for Hereditary Diseases in Brazil's Un
Phase N/A · 27 location(s) · Hospital do Coracao · NCT06546137Assessment of the Effects and Safety of Spermidine Supplementation on Blood Lipids and Body Weight in Overweight or Obes
NA · 1 location(s) · Shanghai 10th People's Hospital · NCT07662330A Phase 3 Study of Zodasiran in Adolescent and Adult Subjects With Homozygous Familial Hypercholesterolemia (YOSEMITE)
Phase 3 · 43 location(s) · Arrowhead Pharmaceuticals · NCT07037771A Multicenter Trial Assessing the Impact of Lipoprotein(a) Lowering With Pelacarsen (TQJ230) on the Progression of Calci
Phase 2 · 140 location(s) · Novartis Pharmaceuticals · NCT05646381A Safety and Tolerability Trial Evaluating CTX310 in Participants With Refractory Dyslipidemias
Phase 1 · 19 location(s) · CRISPR Therapeutics AG · NCT07491172
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.